Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
Related stories
Four ways to keep your energy bills down
Taking Ozempic? A routine eye exam could help you understand your risk for vision loss.
SpaceX is moments away from monumental Starship launch
Nvidia launches record $150bn share buyback
Nvidia makes a statement with historic $150 billion buyback announcement
A pullback is brewing, say these strategists who have examined every drawdown since 1956